CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) (USD $)	Convertible Series B Preferred Stock	Common Stock	Additional Paid-In Capital	Employee Advances	Treasury Stock	Accumulated Deficit	Total
Beginning Balance, Amount at Dec. 31, 2012	$ 395	$ 13,031	$ 16,460,385	$ (18,858)	$ (3,419,715)	$ (20,828,674)	$ (7,793,436)
Beginning Balance, Shares at Dec. 31, 2012	394,685	13,030,397			1,179,212
Stock-based compensation			330,021				330,021
Warrants issued to 2012 private placement investors			487,200				487,200
Issuance of Series B preferred stock as payment-in-kind for dividend, Amount	27		261,057				261,084
Issuance of Series B preferred stock as payment-in-kind for dividend, Shares	27,630
Cashless exercise of warrants into common stock, Amount		6,934	(6,934)
Cashless exercise of warrants into common stock, Shares		6,934,784
Contractual dividends on Series B convertible preferred stock						(69,840)	(69,840)
Beneficial conversion feature and deemed dividend on Series B convertible preferred stock			1,532,722			(1,532,722)
Warrants issued as debt discount in connection with notes payable			315,300				315,300
Conversion of notes and accounts payable into common stock and warrants, Amount		833	3,625,067				3,625,900
Conversion of notes and accounts payable into common stock and warrants, Shares		833,000
Issuance of common stock and warrants for cash, Amount		3,377	3,373,598				3,376,975
Issuance of common stock and warrants for cash, Shares		3,376,975
Imputed value of services contributed			87,500				87,500
Reduction in value of employee advance reserve				(31,528)			(31,528)
Net loss						(4,078,366)	(4,078,366)
Ending Balance, Amount at Mar. 31, 2013	$ 422	$ 24,175	$ 26,465,916	$ (50,386)	$ (3,419,715)	$ (26,509,602)	$ (3,489,190)
Ending Balance, Shares at Mar. 31, 2013	422,315	24,175,156			1,179,212